These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18817258)

  • 1. Continuation rates and reasons for discontinuing TCu380A IUD use in Sari, Iran.
    Khademloo M; Ghasemian R; Yasari M
    Pak J Biol Sci; 2008 Jun; 11(11):1514-6. PubMed ID: 18817258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation rates and reasons for discontinuing TCu380A IUD use in Tabriz, Iran.
    Jenabi E; Alizade SM; Baga RI
    Contraception; 2006 Dec; 74(6):483-6. PubMed ID: 17157106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D; Davie J; Glasier A
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of clinical effects of VCu IUD and TCu380A IUD were used on women who once been done cesarean section].
    Tang YH; Feng ZJ
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1209-11. PubMed ID: 22883013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial.
    Hubacher D; Schreiber CA; Turok DK; Jensen JT; Creinin MD; Nanda K; White KO; Dayananda I; Teal SB; Chen PL; Chen BA; Goldberg AB; Kerns JL; Dart C; Nelson AL; Thomas MA; Archer DF; Brown JE; Castaño PM; Burke AE; Kaneshiro B; Blithe DL
    EClinicalMedicine; 2022 Sep; 51():101554. PubMed ID: 35865736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD.
    Rivera R; Chen-Mok M; McMullen S
    Contraception; 1999 Sep; 60(3):155-60. PubMed ID: 10640159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women.
    Wu S; Hu J; Wildemeersch D
    Contraception; 2000 Feb; 61(2):91-8. PubMed ID: 10802273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of intrauterine devices: TCu380A and Flexigard].
    Andrade AT; Araujo DA; Abranches AA
    Bol Cent Biol Reprod; 1993; 12(1):16-9. PubMed ID: 12345520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of copper intrauterine devices when inserted after an expulsion.
    Bahamondes L; Díaz J; Marchi NM; Petta CA; Cristofoletti ML; Gomez G
    Hum Reprod; 1995 Nov; 10(11):2917-8. PubMed ID: 8747044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the personal reasons for discontinuing IUD use.
    Petta CA; Amatya R; Farr G; Chi I
    Contraception; 1994 Oct; 50(4):339-47. PubMed ID: 7813222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do insertion-related problems affect subsequent IUD performance?
    Chi IC; Waszak CS; Wilkens LR
    Contraception; 1986 Nov; 34(5):497-503. PubMed ID: 3816233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
    Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
    Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter comparative study of UCu200, TCu380A, and medicated γ-IUD devices inserted immediately after vacuum aspiration.
    Hu X; Li L; Zou Y; Wu S
    Int J Gynaecol Obstet; 2013 Jul; 122(1):65-9. PubMed ID: 23562589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight years with the same IUD.
    Bonacho I; Pita S; Gómez-Besteiro MI
    Contraception; 1999 Apr; 59(4):233-6. PubMed ID: 10457867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.